Anti-Obesity Drugs Market, by Drug Class (Peripherally Acting Anti-Obesity Drugs and Centrally Acting Anti-Obesity Drugs), by Medication Type (Monotherapy and Polytherapy), by Drug Type (Prescription Drugs and OTC Drugs), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019–2026

  • To Be Published : Aug 2019 |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Anti-obesity Drugs are pharmacological agents that reduce or control the weight. These drugs change one of the fundamental processes of human body, weight regulation, either by changing the absorption of calories or dipping the hunger. Appetite control is achieved by using the agonists for appetite suppressing pathways. Various anti-obesity drugs, which are approved from the past decade such as knoll and acomplia (romonabant) are removed, as they cause suicidal thoughts, depression, and cardiovascular problems, due to their long-term usage.

Global Anti-Obesity Drugs Market- Dynamics

Increasing prevalence of obesity, adoption of deskbound lifestyle, increasing geriatric population, and chronic nature of disease is expected to augment market growth. Furthermore, faulty eating habits and rising consumption of fast food coupled with lack exercise is driving the market globally. In October 2018, Novo Nordisk launched new obesity treatment on world obesity day. The company announced the availability of Saxenda in Singapore, which is a Health Sciences Authority (HSA) approved injectable medicine that is used with low calorie meal plan and helps the adults who are obese or who are overweight with at least one weight associated medical problem to lose weight.

Basic activities such reducing the intake of unhealthy food and inculcating workout are not seen to be highly effective, and the medical devices such as intragastric balloon and bariatric surgery have complications and are highly expensive. All this shows difficulties in treatment of obesity. These unmet needs are driving growth of global anti-obesity drugs market. For instance, in September, 2014, the U.S. FDA’s approved a new prescription weight loss pill- Contrave for obese adults, the new drug is the third prescription weight loss drug approved by the FDA.

Global Anti-Obesity Drugs Market- Regional Dynamics

North America has witnessed significant growth in the recent past, owing to high level of awareness among the people with obesity and the higher risks associated with the medical condition, rise in healthcare expenditure, extensive and effective research and development activities, involvement of government and non-government organizations in creating an awareness and funding the research and higher number of adults with obesity in the region. According to the World Health Organization, in 2016, over 1.9 billion adults who were aged 18 years and above were overweight and of these over 650 million were obese.

Global Anti-Obesity Drugs Market- Competitive Analysis

Manufactures are focused on development, manufacturing, and marketing of multisource and branded pharmaceuticals. Key players in the global anti-obesity drug market are innovating new and efficient anti-obesity drugs by adopting novel strategies to meet the demand from customers with various types of obesity problems. For instance, in 2017, Boehringer Ingelheim GmbH and Gubra announced collaboration and license agreement for the development of novel peptide compounds to treat the obesity. Furthermore, in March, 2019, Merck and Co and NGM Biopharmaceuticals developed new range of obesity management drugs.

Key players operating in the global anti-obesity drugs market include Arena Pharmaceuticals Inc., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Orexigen Therapeutics Inc., Norgine B.V., Pfizer Inc., Merck Co& Inc., Takeda Pharmaceuticals Co. Ltd., Zydus Cadila, Novo Nordisk, Zafgen, GlaxoSmithKline PLC, and Hoffmann-La Roche AG   

Global Anti-Obesity Drugs Market- Market Taxonomy

On the basis of drug class, the global anti-obesity drugs market is segmented into:

  • Peripherally Acting Anti-Obesity Drugs
  • Centrally Acting Anti-Obesity Drugs

On the basis of medication type, the global anti-obesity drugs market is segmented into:

  • Monotherapy
  • Polytherapy

On the basis of drug type, the global anti-obesity drugs market is segmented into:

  • Prescription Type Drugs
  • Over-the-counter(OTC) Drugs

On the basis of region, the global anti-obesity drugs market is segmented into:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.